Raquel Hladun

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma.

Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma.

Journal: Pediatric blood & cancer

Published: May 04, 2026

Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.

Loss of BAX in a neuroblastoma patient reveals delayed apoptosis but sustained chemotherapy sensitivity.

Journal: NPJ precision oncology

Published: December 18, 2025

Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.

Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma.

Journal: Cancers

Published: August 26, 2025

Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 27, 2025

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.

Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 07, 2025

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 06, 2025

Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study.

Parameningeal Rhabdomyosarcoma: Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 Study.

Journal: Head & neck

Published: May 22, 2024

Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.

Recommendations for the use of nuclear medicine imaging in patients with neuroblastoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 29, 2024

Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial.

Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial.

Journal: Pediatric blood & cancer

Published: February 27, 2024

ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.

ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 09, 2024

Targeting the Hedgehog Pathway in Rhabdomyosarcoma.

Targeting the Hedgehog Pathway in Rhabdomyosarcoma.

Journal: Cancers

Published: January 13, 2023

Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma.

Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma.

Journal: Targeted oncology

Published: October 31, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026